The aim of this study was to assess medical students’ perception of pharmacological cognitive enhancement (PCE) with methylphenidate and to determine whether this perception differs between junior and senior medical students.
The second and fifth year medical student groups of 2017 at a specific university completed self-administered questionnaires in order to investigate if there were a difference in their attitudes towards methylphenidate use for PCE.
A total of 353 students were included as follows: 135 second year and 218 fifth year students. Fifth year students were more aware of PCE with methylphenidate than second year students (94% versus 87%; p value = 0.02). Many students (second year = 86%; fifth year = 71%; p value = 0.2469) were of the opinion that methylphenidate could enhance academic performance. Sixty-six percent of all the students were concerned about the fairness of PCE; 93% were concerned about the harmfulness of methylphenidate. There were no statistical significant differences in the attitudes towards methylphenidate use for PCE between the two groups of junior and senior students.
In both groups, the majority of students were against the use of methylphenidate for PCE in students without attention deficit and hyperactivity disorder. Their attitudes regarding the use of methylphenidate for non-medical purposes did not differ significantly. Addressing the topic of PCE with medical students is essential, and the impact on their practice can be an important direction for future research.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Bostrom N, Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics. 2009;15(3):311–41.
Forlini C, Schildmann J, Roser P, Beranek R, Vollmann J. Knowledge, experiences and views of German university students toward neuroenhancement: an empirical-ethical analysis. Neuroethics. 2015;8(2):83–92.
Gunter TD. Cosmetic neurocognitive enhancement and healthcare providers. Indiana Health Law Review. 2015;12(2):729.
Farah MJ, Smith ME, Ilieva I, Hamilton RH. Cognitive enhancement. Wiley Interdiscip Rev Cogn Sci. 2014;5(1):95–103.
Franke AG, Bagusat C, Rust S, Engel A, Lieb K. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):83–90.
Kasturi VM, Aude B, Gabija D, Ross C, Oonagh C, Ilina S. Towards a moral ecology of pharmacological cognitive enhancement in British Universities. 2017.
Hyman SE. Cognitive enhancement: promises and perils. Neuron. 2011;69(4):595–8.
Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, et al. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci. 2004;5(5):421–5.
Schelle KJ, Faulmuller N, Caviola L, Hewstone M. Attitudes toward pharmacological cognitive enhancement-a review. Front Syst Neurosci. 2014;8:53.
Scheske C, Schnall S. The ethics of “smart drugs”: Moral judgments about healthy people's use of cognitive-enhancing drugs. Basic Appl Soc Psychol. 2012;34(6):508–15.
Dubljević V, Ryan CJ. Cognitive enhancement with methylphenidate and modafinil: conceptual advances and societal implications. Neurosci Neuroecon. 2015;4:25–33.
Franke AG, Bonertz C, Christmann M, Engeser S, Lieb K. Attitudes toward cognitive enhancement in users and nonusers of stimulants for cognitive enhancement: a pilot study. AJOB Prim Res. 2012;3(1):48–57.
Schuijff M, Brom FWA. The dynamics of citizen deliberation regarding human enhancement in the Netherlands. In: Vedder A, Lucivero F (eds) Beyond Therapy v. Enhancement? Multidisciplinary analyses of a heated debate. Robolaw Series. Pisa: Pisa University Press. 2013;143–161.
Bell S, Partridge B, Lucke J, Hall W. Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics. 2013;6(1):197–205.
Cabrera LY, Fitz NS, Reiner PB. Reasons for comfort and discomfort with pharmacological enhancement of cognitive, affective, and social domains. Neuroethics. 2015;8(2):93–106.
Maier LJ, Liakoni E, Schildmann J, Schaub MP, Liechti ME. Swiss university students’ attitudes toward pharmacological cognitive enhancement. PLoS One. 2015;10(12):e0144402.
Maslen H, de Sio FS, Faber N. With cognitive enhancement comes great responsibility? In: Responsible Innovation 2. Berlin: Springer; 2015. p. 121–38.
Riddell C, Jensen C, Carter O. Cognitive enhancement and coping in an Australian University Student Sample. Journal of Cognitive Enhancement. 2017;2(1):63–69.
Emanuel RM, Frellsen SL, Kashima KJ, Sanguino SM, Sierles FS, Lazarus CJ. Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students. J Gen Intern Med. 2013;28(8):1028–34.
Cohen YG, Segev RW, Shlafman N, Novack V, Ifergane G. Methylphenidate use among medical students at Ben-Gurion University of the Negev. J Neurosci Rural Pract. 2015;6(3):320.
Singh I, Bard I, Jackson J. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One. 2014;9(10):e105969.
Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44(02):60–6.
Retief M, Verster C. Prevalence and correlates of non-medical stimulants and related drug use in a sample of South African undergraduate medical students. S Afr J Psychiatry. 2016;22(1):1–6.
Steyn F. Methylphenidate use and poly-substance use among undergraduate students attending a South African university. S Afr J Psychiatry. 2016;22(1):1–4.
Jain R, Chang C, Koto M, Geldenhuys A, Nichol R, Joubert G. Non-medical use of methylphenidate among medical students of the University of the Free State. S Afr J Psychiatry. 2017;23(1):1–5.
Vagwala MK, Bicquelet A, Didziokaite G, Coomber R, Corrigan O, Singh I. Towards a moral ecology of pharmacological cognitive enhancement in British universities. Neuroethics. 2017;10(3):389–403.
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31.
Pohl S, Boelsen H, Hildt E. Moral attitudes towards pharmacological cognitive enhancement (PCE): differences and similarities among Germans with and without PCE experience. Front Pharmacol. 2018;9:1451.
Klinge C, Shuttleworth C, Muglia P, Nobre AC, Harmer CJ, Murphy SE. Methylphenidate enhances implicit learning in healthy adults. J Psychopharmacol. 2018;32(1):70–80.
Beyer C, Staunton C, Moodley K. The implications of methylphenidate use by healthy medical students and doctors in South Africa. BMC Med Ethics. 2014;15(1):20.
Lakhan SE, Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behavior. 2012;2(5):661–77.
Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01600.
Ram S, Hussainy S, Henning M, Stewart K, Jensen M, Russell B. Attitudes toward cognitive enhancer use among New Zealand tertiary students. Subst Use Misuse. 2017;52(11):1387–92.
We would like to acknowledge the valuable contributions by the medical students who participated in this study.
On behalf of both authors, the corresponding author states that there is no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Erasmus, N., Kotzé, C. Medical Students’ Attitudes Towards Pharmacological Cognitive Enhancement With Methylphenidate. Acad Psychiatry 44, 721–726 (2020). https://doi.org/10.1007/s40596-020-01303-z
- Medical students
- Pharmacological cognitive enhancement